Onkos Surgical

Onkos Surgical is a private, commercial-stage medical device company focused on the underserved niche of musculoskeletal oncology and complex orthopaedic reconstruction. The company differentiates itself through a surgeon-driven, patient-inspired approach, leveraging proprietary technologies like the FDA-cleared NanoCept antibacterial coating and 3D-printed BioGrip® technology to address critical clinical challenges such as infection, implant loosening, and soft tissue attachment. With products adopted by over 350 leading US academic medical institutions, Onkos is positioned as an innovator in limb salvage and personalized orthopaedic solutions, though it faces risks from competition, market size, and regulatory dependencies.

Integrated platform featuring NanoCept antibacterial implant coating, BioGrip 3D-printed porous metal for tissue integration, and the My3D digital suite for patient-specific planning and instrumentation.

Onkos competes in a specialized segment against large orthopaedic companies (e.g., Stryker, Zimmer Biomet) that offer oncology solutions within broader portfolios, and potentially against other niche players. Its primary differentiation is its dedicated focus on the oncology/complex reconstruction patient, the FDA-granted NanoCept antibacterial technology, and its integrated personalized planning platform.